Professor of Medicine
Dana-Farber Cancer Institute
Boston, Massachusetts
Jose Cancelas is a hematologist with a broad background in transfusion medicine, cell therapies, hematology, and stem cell biology. He is the executive director of the Connell and O’Reilly Families Cell Manipulations Core Facility at Dana Farber Cancer Institute (DFCI), Professor of Medicine, Harvard Medical School, in Boston, Massachusetts, and member of the DFCI/Harvard Cancer Center and the Harvard Stem Cell Institute. He and his team are responsible for managing a research portfolio on translational and clinical studies involving novel blood derived therapeutics. Previously, he was the Director of Hoxworth Blood Center, a center with national and international reputation in developing and validating new blood products for transfusion and transplantation; and the Executive Director of the Translational Core Laboratories of Cincinnati Children’s Hospital Medical Center, a center specialized in product development gene modified cell products. His research group in hematopoiesis and hemotherapy has been funded by the NIH since 2008 and published over 230 peer-reviewed manuscripts.
Disclosure information not submitted.